Propofol and remifentanil total intravenous anesthesia for a patient with Huntington disease

MacPherson, P. , Harper, I. and MacDonald, I. (2004) Propofol and remifentanil total intravenous anesthesia for a patient with Huntington disease. Journal of Clinical Anesthesia, 16(7), pp. 537-538. (doi: 10.1016/j.jclinane.2003.12.011) (PMID:15590259)

Full text not currently available from Enlighten.

Abstract

Huntington disease presents many challenges for the anesthetist. Of primary importance is that these patients are at increased risk of pulmonary aspiration. The use of short-acting anesthetic drugs should, therefore, be advantageous in promoting the rapid return of protective airway reflexes. We report the first documented use, to date, of propofol and remifentanil total intravenous anesthesia in a patient with Huntington disease and demonstrate its efficacy and safety.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:MacPherson, Professor Peter
Authors: MacPherson, P., Harper, I., and MacDonald, I.
College/School:College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Public Health
Journal Name:Journal of Clinical Anesthesia
Publisher:Elsevier
ISSN:0952-8180

University Staff: Request a correction | Enlighten Editors: Update this record